DELPACIBART BRAXLOSIRAN SODIUM
UNII FE63ZVA6DP

Substance Identification & Data

This profile provides standardized clinical and technical data for Delpacibart Braxlosiran Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FE63ZVA6DP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2929261-85-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FE63ZVA6DP
CAS Registry Number
2929261-85-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DELPACIBART BRAXLOSIRAN SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211752
National Cancer Institute reference terminology for clinical and research data.
INN ID
13251
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Delpacibart Braxlosiran Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DELPACIBART BRAXLOSIRAN SODIUM
IMMUNOGLOBULIN G1 (233-ALANINE,234-ALANINE,327-ARGININE,DE-446-LYSINE), ANTI-(HUMAN TRANSFERRIN RECEPTOR 1) (HUMAN-MUS MUSCULUS MONOCLONAL AV01 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AV01 .KAPPA.-CHAIN, DIMER, REDUCED, 214(OR 219)-THIOETHER WITH RNA (CM-SP-GM-SP-AM-CM-GM-GM-(2'-DEOXY-2'-FLUORO)A-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)A-CM-UM-CM-GM-UM-UM-UM-GM-SP-GM-SP-AM), 5'-(6-(((4-((3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)METHYL)CYCLOHEXYL)CARBONYL)AMINO)HEXYL HYDROGEN PHOSPHATE), COMPLEX WITH RNA (UM-SP-(2'-DEOXY-2'-FLUORO)C-SP-CM-AM-AM-(2'-DEOXY-2'-FLUORO)A-CM-GM-AM-GM-UM-CM-UM-(2'-DEOXY-2'-FLUORO)C-CM-(2'-DEOXY-2'-FLUORO)G-UM-CM-GM-SP-UM-SP-UM) SODIUM
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TFRC (TRANSFERRIN RECEPTOR, TFR1, TFR1, CD71)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF ONE CYSTEINYL RESIDUE VIA A 4-(MALEIMIDOMETHYL)CYCLOHEXANECARBOXAMIDE LINKER WITH A DOUBLE-STRANDED SMALL INTERFERING RNA (SIRNA) (BRAXLOSIRAN) SODIUM

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus